BUDGETS
ACCESS TO YOUR TESTS
MY RESULTS
PROFESSIONAL ACCESS
Description
SAMPLE TYPE: BLOOD
Requires venous extraction
RESULTS: 20 DAYS
Results delivered from sample reception
The GNT. Fertility. HLA-C/KIR evaluates genetic markers involved in maternal-fetal immunological tolerance. It integrates the HLA-C ligand (C1/C2 groups), the KIR haplotype (A/B profile and content of activating/inhibitory genes).
Its objective is to support the diagnosis and stratification of reproductive risk, guiding decisions in assisted reproduction, prevention of complications, and personalized management of pregnancy.
Performing this test requires a medical prescription. The requesting healthcare professional must ensure that the patient receives appropriate genetic information and counseling, as well as the correct clinical interpretation of the results.
- Unexplained infertility and recurrent implantation failure (RIF) in assisted reproduction.
- Recurrent pregnancy loss (RPL) and history of growth restriction or preeclampsia.
- Planning transfers with egg or embryo donation, where the KIR/HLA-C axis may be relevant.
- HLA-C: C1/C2 ligand typing.
- KIR: A/B haplotype
For more information, contact the Teletest administration department at 932 12 33 45 or through the following form
